Taken together, these results demonstrated that BAF180 re-expression reduces cell survival/proliferation in BAF180-deficient RCC4 and SLR25 cells, consistent with a reported tumor-suppressive role of BAF180 in some ccRCC cell lines.7, 28, 29. This evidence concerns the gene SLC49A4 and nonpapillary renal cell carcinoma.